Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2007 Nov 28:7:44.
doi: 10.1186/1471-230X-7-44.

Peroxisome proliferators-activated alpha agonist treatment ameliorates hepatic damage in rats with obstructive jaundice: an experimental study

Affiliations

Peroxisome proliferators-activated alpha agonist treatment ameliorates hepatic damage in rats with obstructive jaundice: an experimental study

Mehmet Cindoruk et al. BMC Gastroenterol. .

Abstract

Background: Peroxisome proliferators-activated receptor alpha (PPARalpha) activation modulates cholesterol metabolism and suppresses bile acid synthesis. This study aims to evaluate the effect of short-term administration of fenofibrate, a PPARalpha agonist, on proinflammatory cytokines, apoptosis, and hepatocellular damage in cholestasis.

Methods: Forty male Wistar rats were randomly divided into four groups: I = sham operated, II = bile duct ligation (BDL), III = BDL + vehicle (gum Arabic), IV = BDL + fenofibrate (100 mg/kg/day). All rats were sacrificed on 7th day after obtaining blood samples and liver tissue. Total bilirubin, aminotransferase (AST), alanine aminotransferase (ALT) and alkaline phosphatase (ALP), gamma-glutamyl transferase, (GGT), tumor necrosis factor alpha (TNF-alpha), interleukin 1 beta (IL-1 beta), and total bile acid (TBA) in serum, and liver damage scores; portal inflammation, necrosis, bile duct number, in liver tissue were evaluated. Apoptosis in liver was also assessed by immunohistochemical staining.

Results: Fenofibrate administration significantly reduced serum total bilirubin, AST, ALT, ALP, and GGT, TNF-alpha, IL-1 beta levels, and TBA (P < 0.01). Hepatic portal inflammation, hepatic necrosis, number of the bile ducts and apoptosis in rats with BDL were more prominent than the sham-operated animals (P < 0.01). PPARalpha induction improved all histopathologic parameters (P < 0.01), except for the number of the bile duct, which was markedly increased by fenofibrate therapy (P < 0.01).

Conclusion: Short-term administration of fenofibrate to the BDL rats exerts beneficial effects on hepatocellular damage and apoptosis.

PubMed Disclaimer

Figures

Figure 1
Figure 1
H & E-stained liver sections of sham operated (A) and BDL (B) rats demonstrate bile-duct dilation, polymorphonuclear cell infiltrate, bile-duct proliferation (arrow, HE × 20), (C) markedly inflammation, and (D) necrosis (arrow, HE × 200).
Figure 2
Figure 2
TUNEL-positive cells per field. Apoptosis in rats with BDL was significantly higher than sham-operated rats (P < 0.01, Kruskal-Wallis test). BDL = Bile duct ligation, BDL + F = BDL + fenofibrate, BDL + V = BDL + vehicle.

Similar articles

Cited by

References

    1. Trauner M, Meierer PJ, Boyer JL. Molecular pathogenesis of cholestasis. New Eng J Med. 1998;39:1217–1227. doi: 10.1056/NEJM199810223391707. - DOI - PubMed
    1. Miyoshi H, Rust C, Roberts PJ, Burgart LJ, Gores GJ. Hepatocyte apoptosis after bile duct ligation in the mouse involves Fas. Gastroenterology. 1999;117:669–677. doi: 10.1016/S0016-5085(99)70461-0. - DOI - PubMed
    1. Allen RT, Hunter WJ, 3rd, Agrawal DK. Morphological and biochemical characterization and analysis of apoptosis. J Pharm Toxicol Methods. 1997;37:215–228. doi: 10.1016/S1056-8719(97)00033-6. - DOI - PubMed
    1. Patel T, Bronk SF, Gores GJ. Increases of intracellular magnesium promote glycodeoxycholate-induced apoptosis in rat hepatocytes. J Clin Invest. 1994;94:2183–2192. - PMC - PubMed
    1. Gonzalez FJ, Peters JM, Cattley RC. Mechanism of action of the nongenotoxic peroxisome proliferators: role of the peroxisome proliferator-activator receptor alpha. J Natl Cancer Inst. 1998;18:1702–1719. doi: 10.1093/jnci/90.22.1702. - DOI - PubMed

MeSH terms

LinkOut - more resources